Articles tagged "Donors"

2018 American Transplant Congress
Use of HCV Ab+/NAT- Donors in HCV Naïve Renal Transplant Recipients
A. Dao,¹ M. Cuffy,¹ T. Kaiser,¹ A. Loethen,¹ J. Cafardi,² A. Shields,² M. Cardi,² R. Alloway,¹ A. Govil,¹ K. Sherman,¹ S. Shah,¹ E. Woodle.¹
¹Univeristy of Cincinnati Medical Center, Cincinnati, OH; ²The Christ Hospital, Cincinnati, OH.
The continued organ shortage in renal transplantation (RT) has stimulated use of organs from increased-risk donors to expand the donor pool. The rate of denovo…
2018 American Transplant Congress
Economic Evaluation of Contemporary Kidney Transplant Practice
D. Axelrod,¹ M. Schnitzler,² H. Xiao,² W. Irish,³ J. Tuttle-Newhall,³ S-.H. Chang,⁴ B. Kasiske,⁵ T. Alhamad,⁴ K. Lentine.²
¹Lahey Clinic, Burlington; ²Saint Louis University, St. Louis; ³East Carolina University, Greeneville; ⁴Washington University, St. Louis; ⁵Hennepin County, Minneapolis.
Kidney transplantation (KTx) has been established as the optimal therapy for medically suitable patients with end-stage renal disease, prolonging survival and reducing health care spending.…
2018 American Transplant Congress
Antiviral Therapy for Donor-Derived Hepatitis C Virus Infection after Solid Organ Transplantation
A. Kwong,¹ A. Wall,² M. Melcher,² U. Wang,³ A. Ahmed,¹ K. Khush,³ A. Subramanian,³ J. Tan,³ P. Kwo.¹
¹Gastroenterology and Hepatology, Stanford University, Palo Alto, CA; ²Surgery, Stanford University, Palo Alto, CA; ³Stanford University, Palo Alto, CA.
Background: In the context of organ shortage, the opioid epidemic, and the advent of effective direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV), more…
2018 American Transplant Congress
DCD Utilization in Cholestatic Liver Disease: Distinct Outcomes between PSC and PBC Recipients
J. Pasko, E. Maynard, E. Dewey, K. Roayaie, S. Orloff, D. Scott, W. Naugler, J. Ahn, C. Enestvedt.
Abdominal Transplant Surgery, Oregon Health & Science University, Portland, OR.
Background: Concern for inferior outcomes in patients with primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) have limited utilization of donation after cardiac death…
2018 American Transplant Congress
The Kidney Allocation System from the Perspective of a Small Program in a Donor Service Area
K. Brown,² S. Hill,² L. Lipscomb,² A. Jones,² S. Hanna,² J. Africa.¹
¹Glickman Institute, Cleveland Clinic, Cleveland, OH; ²Urology and Renal Transplant, Charleston Area Medical Center, Charleston, WV.
This study investigated the impact of the new kidney allocation system (KAS) on a small transplant program (SP) when compared with the 3 other centers…
2018 American Transplant Congress
The Influence Factors of DCD Donors' Family Members' Willingness in Chinese Current Status (Hunan Province Experience)
B. Tu, C. Li, C. Li, S. Liu, Y. Zhao, X. She, Y. Ming.
Transplantation Center of the 3rd Xiangya Hospital, Central South University, Changssha, Hunan, China.
Background: Organ donation after citizen death (DCD) in China has developed gradually since the government promotes it powerfully from 2012, but the donation rate in…
2018 American Transplant Congress
UPMC Living Donor Champion Program
C. Caruso, C. Zell, G. Swaytha, B. Angela, S. Sarah, L. Elaine, P. Susan, W. Travis, H. Abhinav.
Transplant Services, University of Pittsburgh Medical Center, Pittsburgh, PA.
Aims: Living donation is a good option to address organ shortage and waitlist mortality, but finding a living donor can be a challenge. The goal…
2018 American Transplant Congress
Excellent Long Term Outcomes Transplanting Single Pediatric Kidneys from Donors Five Years and Younger into Adult Recipients
R. Shah,¹ M. Aull,² A. Watkins,² S. Kapur.²
¹Department of Surgery, Lincoln Medical Center, New York, NY; ²Surgery/Transplant Surgery, NewYork-Presbyterian/Weill Cornell Medical College, New York, NY.
Pediatric kidneys have been traditionally considered marginal organs for transplantation & are underutilized given concerns of poor outcomes. Furthermore, long term outcomes of single kidneys…
2018 American Transplant Congress
Hypothermic Oxygenated Machine Perfusion in Liver and Kidney Transplantation of Extended Criteria Donors: A Phase-1 of Clinical Trial
M. Ravaioli,¹ V. De Pace,¹ M. Cescon,¹ M. Del Gaudio,¹ V. R. Bertuzzo,¹ A. Siniscalchi,¹ A. D'Errico,² G. Comai,² G. La Manna,² A. D. Pinna.¹
¹General Surgery and Transplantation, University of Bologna Sant'Orsola - Malpighi Hospital, Bologna, Emilia Romagna, Italy; ²Experimental Diagnostic and Specialty Medicine, University of Bologna Sant'Orsola- Malpighi Hospital, Bologna, Emilia Romagna, Italy.
In the field of liver (LT) and kidney transplantation (KT), extended criteria donors (ECD) offer an additional organ source that is more vulnerable for early…
2017 American Transplant Congress
Assessment and Transplantation of Declined Human Kidneys Using Ex-Vivo Normothermic Kidney Perfusion.
S. Hosgood,¹ M. Hamed,¹ A. Sawpaul,² R. Figueiredo,² K. Saeb-Parsy,¹ C. Wilson,² M. Nicholson.¹
¹Department of Surgery, University of Cambridge, Cambridge, United Kingdom; ²Transplantation, Transplant Institute, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
PurposeThe aim of this study was to make more kidneys available for transplantation by using ex-vivo normothermic kidney perfusion (EVKP) technology to assess the quality…